Effect of time after transplantation on microbiology of urinary tract infections among renal transplant recipients

Transplant Infectious Disease

Volumn 10, Issue 2, 2008, Pages 145-148

  Sharma, M ^b,c   Rani, S ^b   Johnson, L B ^a,b,c  

^a St John Hospital and Medical Center ^*  (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Microbiology; Renal transplant; Resistance; Timing; Urinary tract infections

Indexed keywords

AMPICILLIN; AZATHIOPRINE; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; KIDNEY GRAFT; KLEBSIELLA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; PROPHYLAXIS; STAPHYLOCOCCUS AUREUS; URINALYSIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

EID: 40849100247     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00263.x     Document Type: Article

References (10)

1. Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE. Infection in the renal transplant recipient. Am J Med 1981 70 : 405 411.
2. Fox BA, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxsis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on microflora, and cost-benefit of prophylaxis. Am J Med 1990 89 : 255 274.
3. Moysés-Neto M, Costa RS, Reis MA, et al. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients. Clin Transplant 1997 11 : 446 452.
4. Abbott KC, Swanson SJ, Richer ER, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004 44 : 353 362.
5. Wagener MM, Yu VL. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992 20 : 239 247.
6. Takai K, Tollermar J, Wilczek HE, Groth CG. Urinary tract infections following renal transplantation. Clin Transplant 1998 12 : 19 23.
7. Maraha B, Bonten H, Hooff HV, Fiolet H, Buiting AG, Stobberingh EE. Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. Clin Microbiol Infect 2001 7 : 619 625.
8. Valera B, Gentil MA, Cabello V, Fijo J, Cordero E, Cisneros JM. Epidemiology of urinary infections in renal transplant recipients. Transplant Proc 2006 38 : 2414 2415.
9. Munoz P. Management of urinary tract infections and lymphocele in renal transplant recipients. Clin Infect Dis 2001 33 (Suppl 1) : S53 S57.
10. Peterson PK, Anderson RC. Infection in renal transplant recipients. Current approaches to diagnosis, therapy, and prevention. Am J Med 1986 81 (1A) : 2 10.